CT Corsearch, part of CT, a Wolters Kluwer business and the premier provider of clearance and protection solutions for trademark and brand professionals, today announced the availability of its new comprehensive trademark search capabilities designed specifically for the specialized needs of the pharmaceutical industry.
Pharmaceutical trademarks are unique in that brands and product names must be cleared with both the U.S. Food and Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO). Each year, the FDA rejects about one-third of the approximately 400 brand names it reviews.
A trademarked name must be dissimilar to other existing names that could cause confusion, which is standard for trademark clearance, and also avoid consumer confusion by ensuring it is not similar to the name of a pre-existing drug or device in the look, sound when spoken and appearance when written.
The new CT Corsearch pharmaceutical trademark search combines key components in the clearance process that cover both standard trademark clearance and name safety components. The result is a big step forward in pharmaceutical clearance that incorporates the FDA's Phonetic Orthographic Computer Analysis (POCA) and summarizes unwieldy name safety data like Adverse Event Reporting System (AERS), Vaccine Adverse Event Reporting System (VAERS) into an easy-to-review summary format and overall, synthesizes name safety into the clearance process.
"Branding is a complex and potentially game-changing task for the pharmaceutical industry, where a particular name can generate millions and even billions of dollars in annual sales," said Stephen Anderson, manager of content development for CT Corsearch. "Our new pharmaceutical trademark search addresses the two-pronged search capabilities required to help these companies be successful in clearing compelling brand names and identities quickly and effectively, so that they can focus on the task of bringing their products to market."
Key features of CT Corsearch's pharmaceutical search include: